← FDA Drug Approvals (Drugs@FDA)
OXACILLIN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2017-09-11
Drug application
- FDA Application #
ANDA206681- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXACILLIN SODIUM
- Generic name
- Oxacillin Sodium
- Active ingredients
- OXACILLIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- PIRAMAL CRITICAL
- First approval
- 2017-09-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown